PPD opened its Brazil office in 1996 and maintains a strong presence in the country. Our experience in conducting clinical trials and strong relationships with investigators and regulators speed timelines and reduce costs throughout the drug development process.
With a population of more than 190 million, Brazil provides access to many treatment-naïve patients at lower costs than the United States and Europe while maintaining an advanced health care infrastructure.
Learn about the benefits and challenges of conducting clinical trials in Latin America. Download our white paper.